You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 16, April 26, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Thrombolysis
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Drug Therapy
 •Adverse Effects
 •Medication Error
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Excess Dosing of Antithrombotic Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes

Since this article does not have an abstract, we have provided the first 103 words of the full text and any section headings.

To the Editor: The study by Dr Alexander and colleagues1 on excess dosing of antiplatelet and antithrombin agents provides critical information on the nature, magnitude, and consequences of an important issue. Given the widespread interest in using electronic medical records and decision support tools to promote accurate prescribing of medications, we are interested in whether the authors explored such relationships in their analyses and whether the presence or absence of electronic medical records was associated with inappropriate dosing.2-3 Although computerized order entry may minimize some errors, other errors may be generated, demonstrating the need to critically evaluate all approaches.4-5

Financial Disclosures: None reported.

David Parra, PharmD
david.parra@med.va.gov

Daniel Woods, MD; Venkataraman Balu, MD
Department of Cardiology

Roy Coakley, MS
Department of Clinical Pharmacy
Veterans Affairs Medical Center
West Palm Beach, Fla

1. Alexander KP, Chen AY, Roe MT, et al, CRUSADE Investigators. Excess dosing of antiplatelet and antithrombin agents in the treatment of non–ST-segment elevation acute coronary syndromes. JAMA. 2005;294:3108-3116. FREE FULL TEXT
2. Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998;280:1311-1316. FREE FULL TEXT
3. Bates DW, Gawande AA. Patient safety: improving safety with information technology. N Engl J Med. 2003;348:2526-2534. FREE FULL TEXT
4. Teich JM, Merchia PR, Schmiz JL, et al. Effects of computerized physician order entry on prescribing practices. Arch Intern Med. 2000;160:2741-2747. FREE FULL TEXT
5. Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA. 2005;293:1197-1203. FREE FULL TEXT

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2006;295:1897.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLES

Excess Dosing of Antithrombotic Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes
Andrew T. Yan, Raymond T. Yan, and Shaun G. Goodman
JAMA. 2006;295(16):1896.
EXTRACT | FULL TEXT  

Excess Dosing of Antithrombotic Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes
Frédéric Lapostolle, Jean Catineau, Claude Lapandry, and Frédéric Adnet
JAMA. 2006;295(16):1896-1897.
EXTRACT | FULL TEXT  

Excess Dosing of Antithrombotic Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes—Reply
Karen P. Alexander and Eric D. Peterson
JAMA. 2006;295(16):1897.
EXTRACT | FULL TEXT  

Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non–ST-Segment Elevation Acute Coronary Syndromes
Karen P. Alexander, Anita Y. Chen, Matthew T. Roe, L. Kristin Newby, C. Michael Gibson, Nancy M. Allen-LaPointe, Charles Pollack, W. Brian Gibler, E. Magnus Ohman, Eric D. Peterson, and for the CRUSADE Investigators
JAMA. 2005;294(24):3108-3116.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.